Marketing-authorisation holder · United Kingdom
Pfizer Limited
66 medicines in 2 countries, as authorisation holder, manufacturer and marketer.
Loading your page…
Loading your page…
Marketing-authorisation holder · United Kingdom
66 medicines in 2 countries, as authorisation holder, manufacturer and marketer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 66
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Sutent | Sunitinib | EU (EMA) | Authorised | 2006 |
| Advasure | Adjuvanted vaccine against classical swine fever | EU (EMA) | Withdrawn | 2001 |
| BENEFIX 1000 UI1000ui · Pulb. + solv. pt. sol. inj. | Coagulation factor ix | Romania | unknown | |
| BENEFIX 2000 UI2000ui · Pulb. + solv. pt. sol. inj. | Coagulation factor ix | Romania | unknown | |
| BENEFIX 250 UI250ui · Pulb. + solv. pt. sol. inj. | Coagulation factor ix | Romania | unknown | |
| BENEFIX 500 UI500ui · Pulb. + solv. pt. sol. inj. | Coagulation factor ix | Romania | unknown | |
| BOSULIF 100 mg100mg · Compr. film. | Bosutinib | Romania | unknown | |
| BOSULIF 500 mg500mg · Compr. film. | Bosutinib | Romania | unknown | |
| CHAMPIX 0,5 mg + 1 mg0.5mg+1mg · Compr. film. | Varenicline | Romania | unknown | |
| CHAMPIX 1mg1mg · Compr. film. | Varenicline | Romania | unknown | |
| Dicural | Difloxacin | EU (EMA) | Withdrawn | 1998 |
| Doxirobe | Doxycycline | EU (EMA) | Withdrawn | 1999 |
| DYNASTAT 40 mg40mg · Pulb. pt. sol. inj. | Parecoxib | Romania | unknown | |
| ECALTA 100mg100mg · Pulb. pt. conc. pt. sol. perf. | Anidulafungin | Romania | unknown | |
| Elelyso | Taliglucerase alfa | EU (EMA) | Refused | |
| ENBREL 25 mg25mg · Pulb. + solv. pt. sol. inj. | Etanercept | Romania | unknown | |
| ENBREL 50 mg50mg · Sol. inj. in seringa preumpluta | Etanercept | Romania | unknown | |
| Exubera | Insulin (human) | EU (EMA) | Withdrawn | 2006 |
| Exulett | EU (EMA) | Refused | ||
| IBRANCE 100mg100mg · Caps. | Palbociclib | Romania | unknown | |
| IBRANCE 125mg125mg · Caps. | Palbociclib | Romania | unknown | |
| IBRANCE 75mg75mg · Caps. | Palbociclib | Romania | unknown | |
| INLYTA 1 mg1mg · Compr. film. | Axitinib | Romania | unknown | |
| INLYTA 5 mg5mg · Compr. film. | Axitinib | Romania | unknown | |
| LYRICA 150 mg150mg · Caps. | Pregabalin | Romania | unknown |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Romania | 45 | 0 | 45 | CompaniesAll medicines |
| European Union (EMA) | 21 | 1 | 20 | CompaniesAll medicines |
Also in the registers of Brazil, Netherlands, Spain, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; October 2026 register, published 7 October 2026; https://assets.publishing.service.gov.uk/media/6ac660fdec9d3aba1e0139d9/MS_Register_-_October_2026.csv; acquired 2026-10-13T22:59:02.704630+00:00; CSV-to-role/site projection is an adaptation under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; Crown copyright MHRA factual register
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.